Livzon Pharmaceutical Group Inc.
SZSE:000513.SZ
34.48 (CNY) • At close November 27, 2023
Overzicht | Financiële gegevens
Bedrijfsnaam | Livzon Pharmaceutical Group Inc. |
Symbool | 000513.SZ |
Munteenheid | CNY |
Prijs | 32.51 |
Beurswaarde | 26,631,898,630 |
Dividendpercentage | 3.97% |
52-weken bereik | 31.72 - 40.67 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Yanggang Tang |
Website | https://www.livzon.com.cn |
An error occurred while fetching data.
Over Livzon Pharmaceutical Group Inc.
Livzon Pharmaceutical Group Inc. engages in the research, development, production, and sale of pharmaceutical products, and active pharmaceutical ingredients and intermediates in the People's Republic of China. The company offers Ilaprazole enteric coated tablets for the treatment of duodenal ulcers and reflux esophagitis; Laprazole sodium for injection to treat peptic
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (CNY)
Cijfers zijn in miljoenen (CNY)